Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics

多西紫杉醇 医学 无容量 吉非替尼 肺癌 无线电技术 肿瘤科 内科学 置信区间 癌症 实体瘤疗效评价标准 临床试验 放射科 表皮生长因子受体 临床研究阶段 免疫疗法
作者
Laurent Dercle,Matthew P. Fronheiser,Liwu Lin,Shuyan Du,Wendy Hayes,David Leung,Amit Roy,Julia Wilkerson,Pengcheng Guo,Antonio Tito Fojo,Lawrence H. Schwartz,Binsheng Zhao
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:26 (9): 2151-2162 被引量:92
标识
DOI:10.1158/1078-0432.ccr-19-2942
摘要

Abstract Purpose: Using standard-of-care CT images obtained from patients with a diagnosis of non–small cell lung cancer (NSCLC), we defined radiomics signatures predicting the sensitivity of tumors to nivolumab, docetaxel, and gefitinib. Experimental Design: Data were collected prospectively and analyzed retrospectively across multicenter clinical trials [nivolumab, n = 92, CheckMate017 (NCT01642004), CheckMate063 (NCT01721759); docetaxel, n = 50, CheckMate017; gefitinib, n = 46, (NCT00588445)]. Patients were randomized to training or validation cohorts using either a 4:1 ratio (nivolumab: 72T:20V) or a 2:1 ratio (docetaxel: 32T:18V; gefitinib: 31T:15V) to ensure an adequate sample size in the validation set. Radiomics signatures were derived from quantitative analysis of early tumor changes from baseline to first on-treatment assessment. For each patient, 1,160 radiomics features were extracted from the largest measurable lung lesion. Tumors were classified as treatment sensitive or insensitive; reference standard was median progression-free survival (NCT01642004, NCT01721759) or surgery (NCT00588445). Machine learning was implemented to select up to four features to develop a radiomics signature in the training datasets and applied to each patient in the validation datasets to classify treatment sensitivity. Results: The radiomics signatures predicted treatment sensitivity in the validation dataset of each study group with AUC (95 confidence interval): nivolumab, 0.77 (0.55–1.00); docetaxel, 0.67 (0.37–0.96); and gefitinib, 0.82 (0.53–0.97). Using serial radiographic measurements, the magnitude of exponential increase in signature features deciphering tumor volume, invasion of tumor boundaries, or tumor spatial heterogeneity was associated with shorter overall survival. Conclusions: Radiomics signatures predicted tumor sensitivity to treatment in patients with NSCLC, offering an approach that could enhance clinical decision-making to continue systemic therapies and forecast overall survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
脑洞疼应助无私的访冬采纳,获得10
4秒前
小二郎应助北冥有鱼采纳,获得10
4秒前
英勇大门完成签到,获得积分10
5秒前
5秒前
耍酷的傲白完成签到,获得积分10
5秒前
英俊的铭应助高工采纳,获得10
5秒前
1717发布了新的文献求助10
5秒前
马六完成签到,获得积分10
5秒前
6秒前
6秒前
6秒前
大个应助超级飞侠采纳,获得50
8秒前
9秒前
st_xp3发布了新的文献求助10
9秒前
11秒前
lailai完成签到,获得积分10
12秒前
Fairyvivi发布了新的文献求助10
12秒前
12秒前
12秒前
13秒前
yina完成签到,获得积分20
13秒前
Eric发布了新的文献求助30
13秒前
14秒前
欢呼的棒棒糖完成签到,获得积分10
14秒前
15秒前
16秒前
16秒前
16秒前
shaw完成签到,获得积分10
17秒前
17秒前
17秒前
桐桐应助Mannose采纳,获得10
18秒前
桓某人发布了新的文献求助10
18秒前
sq1997发布了新的文献求助10
18秒前
lee完成签到,获得积分20
18秒前
lmh发布了新的文献求助10
18秒前
高高高发布了新的文献求助10
19秒前
19秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974712
求助须知:如何正确求助?哪些是违规求助? 3519159
关于积分的说明 11197254
捐赠科研通 3255257
什么是DOI,文献DOI怎么找? 1797724
邀请新用户注册赠送积分活动 877130
科研通“疑难数据库(出版商)”最低求助积分说明 806132